These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27061982)
1. Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies. Pancholia S; Dhameliya TM; Shah P; Jadhavar PS; Sridevi JP; Yogeshwari P; Sriram D; Chakraborti AK Eur J Med Chem; 2016 Jun; 116():187-199. PubMed ID: 27061982 [TBL] [Abstract][Full Text] [Related]
2. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship. Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives. Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents. Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents. Patel SR; Gangwal R; Sangamwar AT; Jain R Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809 [TBL] [Abstract][Full Text] [Related]
6. An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition. Reddy KI; Srihari K; Renuka J; Sree KS; Chuppala A; Jeankumar VU; Sridevi JP; Babu KS; Yogeeswari P; Sriram D Bioorg Med Chem; 2014 Dec; 22(23):6552-6563. PubMed ID: 25456076 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents. Patel SR; Gangwal R; Sangamwar AT; Jain R Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives. Patel KN; Telvekar VN Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents. Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456 [TBL] [Abstract][Full Text] [Related]
10. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862 [TBL] [Abstract][Full Text] [Related]
11. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives. Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525 [TBL] [Abstract][Full Text] [Related]